SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-068345
Filing Date
2023-06-06
Accepted
2023-06-06 08:07:40
Documents
3
Period of Report
2023-06-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2317752-11_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2317752-11_4seq1.xml 4 4729
2 EXHIBIT 24 tm2317752d11_ex24.htm EX-24 8492
3 GRAPHIC tm2317752d11_ex24img001.jpg GRAPHIC 3525
  Complete submission text file 0001104659-23-068345.txt   19759
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B14202 CAMBRIDGE MA 02139
Business Address
Komjathy Andrew (Reporting) CIK: 0001788465 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 23994934